These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14534299)

  • 1. Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth.
    Cheng ZJ; Harikumar KG; Holicky EL; Miller LJ
    J Biol Chem; 2003 Dec; 278(52):52972-9. PubMed ID: 14534299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy.
    Harikumar KG; Clain J; Pinon DI; Dong M; Miller LJ
    J Biol Chem; 2005 Jan; 280(2):1044-50. PubMed ID: 15520004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors.
    Harikumar KG; Pinon DI; Miller LJ
    J Biol Chem; 2006 Sep; 281(37):27072-80. PubMed ID: 16857665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity.
    Cawston EE; Harikumar KG; Miller LJ
    Am J Physiol Cell Physiol; 2012 Feb; 302(3):C615-27. PubMed ID: 22049215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for benzodiazepine agonist action at the type 1 cholecystokinin receptor.
    Harikumar KG; Cawston EE; Lam PCH; Patil A; Orry A; Henke BR; Abagyan R; Christopoulos A; Sexton PM; Miller LJ
    J Biol Chem; 2013 Jul; 288(29):21082-21095. PubMed ID: 23754289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRC regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant.
    Chao C; Ives KL; Goluszko E; Kolokoltsov AA; Davey RA; Townsend CM; Hellmich MR
    J Biol Chem; 2005 Sep; 280(39):33368-73. PubMed ID: 16079138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that interspecies polymorphism in the human and rat cholecystokinin receptor-2 affects structure of the binding site for the endogenous agonist cholecystokinin.
    Langer I; Tikhonova IG; Travers MA; Archer-Lahlou E; Escrieut C; Maigret B; Fourmy D
    J Biol Chem; 2005 Jun; 280(23):22198-204. PubMed ID: 15817487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM; Ji Z; Pinon DI; Henne RM; Lybrand TP; Miller LJ
    J Med Chem; 1999 Jun; 42(12):2105-11. PubMed ID: 10377216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer.
    Cheng ZJ; Miller LJ
    J Biol Chem; 2001 Dec; 276(51):48040-7. PubMed ID: 11673456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual pathways of internalization of the cholecystokinin receptor.
    Roettger BF; Rentsch RU; Pinon D; Holicky E; Hadac E; Larkin JM; Miller LJ
    J Cell Biol; 1995 Mar; 128(6):1029-41. PubMed ID: 7896869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells.
    Dabrowski A; Detjen KM; Logsdon CD; Williams JA
    Digestion; 1997; 58(4):361-7. PubMed ID: 9324163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.
    Herrick-Davis K; Grinde E; Harrigan TJ; Mazurkiewicz JE
    J Biol Chem; 2005 Dec; 280(48):40144-51. PubMed ID: 16195233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization.
    Pfeiffer M; Koch T; Schröder H; Laugsch M; Höllt V; Schulz S
    J Biol Chem; 2002 May; 277(22):19762-72. PubMed ID: 11896051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A.
    Tarasova NI; Stauber RH; Choi JK; Hudson EA; Czerwinski G; Miller JL; Pavlakis GN; Michejda CJ; Wank SA
    J Biol Chem; 1997 Jun; 272(23):14817-24. PubMed ID: 9169450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M; Liu G; Pinon DI; Miller LJ
    Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Bläker M; Ren Y; Gordon MC; Hsu JE; Beinborn M; Kopin AS
    Mol Pharmacol; 1998 Nov; 54(5):857-63. PubMed ID: 9804620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells.
    Detjen K; Yule D; Tseng MJ; Williams JA; Logsdon CD
    Am J Physiol; 1997 Nov; 273(5):C1449-57. PubMed ID: 9374628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced association of mu opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands.
    Zheng Y; Akgün E; Harikumar KG; Hopson J; Powers MD; Lunzer MM; Miller LJ; Portoghese PS
    J Med Chem; 2009 Jan; 52(2):247-58. PubMed ID: 19113864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-independent desensitization and internalization of the human platelet-activating factor receptor by coumermycin-gyrase B-induced dimerization.
    Perron A; Chen ZG; Gingras D; Dupre DJ; Stankova J; Rola-Pleszczynski M
    J Biol Chem; 2003 Jul; 278(30):27956-65. PubMed ID: 12756251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.